Literature DB >> 18227452

Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia.

Howard Chertkow1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18227452      PMCID： PMC2211335          DOI： 10.1503/cmaj.070795

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

2.  Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination.

Authors:  S H Woolf; R N Battista; G M Anderson; A G Logan; E Wang
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

4.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

Review 5.  The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia.

Authors:  C Patterson; S Gauthier; H Bergman; C Cohen; J W Feightner; H Feldman; A Grek; D B Hogan
Journal:  Can J Neurol Sci       Date:  2001-02       Impact factor: 2.104

6.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

Authors:  D A Snowdon; L H Greiner; J A Mortimer; K P Riley; P A Greiner; W R Markesbery
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

7.  The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group.

Authors: 
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

8.  The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada.

Authors: 
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

9.  Canadian study of health and aging: study methods and prevalence of dementia.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

10.  A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results.

Authors:  H Feldman; A R Levy; G-Y Hsiung; K R Peters; A Donald; S E Black; R W Bouchard; S G Gauthier; D A Guzman; D B Hogan; A Kertesz; K Rockwood
Journal:  Neuroepidemiology       Date:  2003 Sep-Oct       Impact factor: 3.282
View more
  32 in total

Review 1.  How applicable are clinical practice guidelines to elderly patients with comorbidities?

Authors:  Donatus R Mutasingwa; Hong Ge; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2011-07       Impact factor: 3.275

Review 2.  Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis.

Authors:  Andrea C Tricco; Charlene Soobiah; Shirra Berliner; Joanne M Ho; Carmen H Ng; Huda M Ashoor; Maggie H Chen; Brenda Hemmelgarn; Sharon E Straus
Journal:  CMAJ       Date:  2013-09-16       Impact factor: 8.262

Review 3.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

Review 4.  Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

5.  Update on the pharmacological treatment of Alzheimer's disease.

Authors:  Fadi Massoud; Serge Gauthier
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

Review 6.  Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease.

Authors:  Christopher Patterson; John W Feightner; Angeles Garcia; G-Y Robin Hsiung; Christopher MacKnight; A Dessa Sadovnick
Journal:  CMAJ       Date:  2008-02-26       Impact factor: 8.262

Review 7.  Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.

Authors:  Nathan Herrmann; Serge Gauthier
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

Review 8.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

9.  Bone lead levels are associated with measures of memory impairment in older adults.

Authors:  Edwin van Wijngaarden; James R Campbell; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2009-05-27       Impact factor: 4.294

Review 10.  Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.